Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  News  >  Business Leaders  >  Business Leaders Biography

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors 
HomeAll newsMost read newsBusiness Leaders Biography
Portrait de Ulf Mark Schneider
Age : 51
Public asset : 197,068 USD
Country of residence : Unknown
Linked companies : Nestle SA

Dr. Ulf Mark Schneider is Chairman-Supervisory Board at EUFETS AG, Chairman-Supervisory Board at Fresenius Medical Care Groupe France SAS and Chairman-Supervisory Board at Fresenius Medical Care Management AG.

He is on the Board of Directors at Nestlé SA, E.I. du Pont de Nemours & Co., DuPont Safety Resources, FPS Beteiligungs AG, NPBI International BV, FHC Holdings Ltd., Fresenius Kabi USA, Inc., Fresenius Hemocare Netherlands B.V. and Fresenius Kabi España SA. Dr. Schneider was previously employed as Chief Financial Officer by Fresenius Medical Care AG & Co. KGaA, Chairman-Management Board by Fresenius SE & Co. KGaA, Chairman-Supervisory Board by Fresenius Kabi AG, Member-Supervisory Board by Fresenius Kabi Austria GmbH, Chairman-Management Board by Fresenius Management SE, Group Finance Director by Gehe UK Plc, and Chairman-Supervisory Board by HELIOS Kliniken GmbH.

He also served on the board at APP Pharmaceuticals, Inc. and Fresenius Kabi Pharmaceuticals Holding, Inc. (United States).

He received his MBA from Harvard Business School and a doctorate degree from the University of St. Gallen.

Current positions of Ulf Mark Schneider 
NameTitle Since
Nestle SA
(Food Processing)
Chief Executive Officer & Director 2016
EUFETS AG Chairman-Supervisory Board -
Fresenius Medical Care Groupe France SAS Chairman-Supervisory Board -
Fresenius Medical Care Management AG Chairman-Supervisory Board -
NPBI International BV Member-Supervisory Board 2004
DuPont Safety Resources Director 2014
Fresenius Hemocare Netherlands B.V. Member-Supervisory Board -
Fresenius Kabi España SA Member-Supervisory Board -
FHC Holdings Ltd. Director -
Société des Produits Nestlé SA Director 2017
FPS Beteiligungs AG Member-Supervisory Board 2012
Fresenius Kabi USA, Inc. Director -

Ulf Mark Schneider : Personal Network 
NameLinked companies
Stephan Sturm Fresenius Kabi España SA
Fresenius Medical Care Management AG
FHC Holdings Ltd.
Fresenius Hemocare Netherlands B.V.
FPS Beteiligungs AG
Rainer Baule NPBI International BV
Fresenius Hemocare Netherlands B.V.
Fresenius Kabi España SA
FHC Holdings Ltd.
Mats Christer Henriksson FHC Holdings Ltd.
Fresenius Kabi USA, Inc.
Fresenius Kabi España SA
Laurent Freixe Nestle SA
Société des Produits Nestlé SA
Peter Brabeck-Letmathe Nestle SA
Ursula Burns Nestle SA
Henri de Castries Nestle SA
Patrick Aebischer Nestle SA
Kam Fun Cheng Li Nestle SA
Peter Blackshaw Nestle SA

Biography of Ulf Mark Schneider 
Ulf Mark Schneider (born 1965) is the current CEO of Fresenius, a $26 billion global health care group.

Life and career
Schneider was born and raised in Germany and became a U.S. citizen in 2003. He holds a doctorate in economics from the University of St. Gallen, Switzerland, and an MBA from Harvard Business School. Schneider joined Fresenius in November 2001 and served as Chief Financial Officer of Fresenius Medical Care before assuming his current position in May, 2003. Previously, he was Group Finance Director for Gehe UK plc., a pharmaceutical wholesale and retail distributor, in Coventry, England. Schneider held several senior executive positions starting in 1989 with Gehe’s majority shareholder, Franz Haniel & Cie. GmbH, a diversified German industrial company. Under Schneider's leadership, Fresenius' revenue has almost tripled, the number of employees has more than tripled and net income has increased approximately eightfold. Since Schneider became CEO, Fresenius has also carried out a number of major strategic acquisitions: the private hospital chain HELIOS Kliniken in 2005; U.S. dialysis provider Renal Care Group, in 2006; U.S. pharmaceutical company APP Pharmaceuticals, in 2008; Liberty Dialysis, another major dialysis provider in the United States, in 2011; and, in 2014, the purchase of 41 hospitals from Rhön-Klinikum, through which HELIOS became the largest private hospital operator in Germany.

The management challenges of global growth and future strategies in the health care and pharmaceutical industries are of particular interest to Schneider.

Schneider chairs the European Advisory Board of Harvard Business School, and serves on the Board of Directors of the American chemical company DuPont.

Source @ Wikipedia

Most Read News 
12/08 JAMIE DIMON : JPMorgan's Dimon taking customer pricing hints from Amazon
12/11DJROBERT IGER : ConsolidationDisney Deal for Fox Would End Hollywood EraFox Would Play Supporting Role at Disney -- WSJ
12/07 LAKSHMI MITTAL : ArcelorMittal's $1 billion India joint venture to get green light next week - sources
12/07 STÉPHANE RICHARD : Orange's boss Richard promises investors more of the same
12/07 MIKHAIL FRIDMAN : BASF agrees oil unit merger with Fridman's DEA to spur expansion
12/12 CARL ICAHN : Xerox 'desperately' needs new leadership, Icahn says
12/07 GEORGE SOROS : Soros-backed GlenPoint opens New York office, co-founder to relocate
12/12 RUPERT STADLER : Audi CEO drops plan to sell motorcycle brand Ducati
12/08 JOHN BROWN : Former BP boss Browne back with what he knows best - oil mergers
12/08 TERRY LUNDGREN : Macy's Executive Chairman Lundgren to retire in January
More news

© 2017 People and Ownership :   
Ulf Mark Schneider : Connections 
Fondation Nationale des Sciences Politiques
W.O.M.E.N. In America, Inc.
NPBI International BV
Chinese People Political Consultative Conference of Guangdong
Wittgensteiner Kliniken GmbH
Calea Ltd.

Latest news about Ulf Mark Schneider 
06/15DJNestlé Exploring Sale of Its U.S. Confectionery Business -- 2nd Update
04/25 Fresenius picks up M&A pace with Akorn, Merck KGaA deals
04/07DJUnilever Joins Race to Shed Food Businesses -- WSJ
04/06DJUnilever to Restructure, Raise Returns in Wake of Kraft Bid -- 6th Update
02/16DJNestle Needs Three-Year 'Time Out' From Organic Growth Target -- CEO
02/16DJNestlé Misses Growth Target for Fourth Straight Year -- Update
02/16DJNestlé Reports Drop in Sales, Profit -- Update
More news

Popular Business Leaders 
William Ackman Jean-paul Agon Liliane Bettencourt Jeff Bezos Lloyd Blankfein Vincent Bolloré John Bryant Warren Buffett Kenneth Chenault Gary Cohn Tim Cook Jean Coutu Jamie Dimon Ralph Dommermuth Patrick Drahi John Edwards Douglas Flint Carlos Ghosn Mario Greco David Henry Heinrich Hiesinger Carl Icahn Bruno Lafont Jack Ma Laurent Mignon Lakshmi Mittal James Murdoch Elon Musk Peter Nicholas Michael O'leary Nelson Peltz Sumner Redstone Franck Riboud Stéphane Richard Xavier Rolet Kasper Rorsted Wilbur Ross Sheryl Sandberg George Soros Ulrich Spiesshofer Johannes Teyssen Peter Thiel François Villeroy De Galhau John Williamson Thomas Wilson Guy Wyser-pratte Dieter Zetsche Mark Zuckerberg Isabel Dos Santos
A-Z Business Leaders